Limitations of the obstetric group B Streptococcus protocol

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 2, 2003, Pages 107-111

  Nemunaitis Keller, Jennifer ^a   Gill, Prabacharan ^a,b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Aultman Health Foundation   (United States)

Author keywords

Centers for Disease Control and Prevention (U.S.); Infectious; Pregnancy complications; Streptococcus Group B

Indexed keywords

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; DELIVERY; FEMALE; GESTATIONAL AGE; HUMAN; MEMBRANE RUPTURE; NONHUMAN; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PRIMARY PREVENTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0037327480     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Allen SR: Management of asymptomatic term neonates whose mothers received intrapartum antibiotics: Part 1. Rationale for intrapartum antibiotic therapy. Clin Pediatr 1997; 36:617-624
2. Schrag SJ, Zywicki S, Farley MM, et al: Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20
3. Centers for Disease Control and Prevention: Adoption of hospital policies for prevention of perinatal group B streptococcal disease - United States, 1997. JAMA 1998;280:958-959
4. Fargason CA, Peralta-Carcelen M, Rouse DJ, et al: The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 1997;90:347-352
5. Hager WD, Schuchat A, Gibbs R, et al: Prevention of perinatal group B streptococcal infection: Current controversies. Obstet Gynecol 2000;96:141-145
6. Mohle-Boetani JC, Schuchat A, Plikaytis BR, et al: Comparison of prevention strategies for neonatal group B streptococcal infection. JAMA 1993;270:1443-1448
7. Rose VL: AAP issues revised guidelines for the prevention of early-onset group B streptococcal infection. Am Fam Physician 1997;56:961-966
8. Rouse DJ, Goldenberg RL, Cliver SP, et al: Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: A decision analysis. Obstet Gynecol 1994;83:483-494
9. Strickland DM, Yeomans ER, Hankins GD: Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization. Am J Obstet Gynecol 1996;163:4-8
10. Yancey MK, Duff P: An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;83:367-371
11. Cheon-Lee E, Amstey MS: Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol 1998;179:77-79
12. Brozanski BS, Jones JG, Krohn MA, et al: Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis. Obstet Gynecol 2000;95: 496-501
13. Davis RL, Hasselquist MB, Cardenas V, et al: Introduction of the new Centers for Disease Control and prevention of group B streptococcal prevention guideline at a large West Coast health maintenance organization. Am J Obstet Gynecol 2001;184:603-610
14. De Cueto M, Sanchez MJ, Sampedro A, et al: Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91: 112-114